Category Lead, Real World Solutions
IQVIA
Dr. Emily Bratton, PhD, has been in the pharmaceutical industry for 15 years, contributing to late-phase observational epidemiology research teams. She is currently Category Lead of Safety Evidence for Regulators in IQVIA's Real World Solutions division. Emily leads the scientific and operational strategies of observational studies (both retrospective and prospective) and low interventional clinical trials intended for regulatory purposes. Her areas of specialization and interest include: post-authorization safety and effectiveness research, pregnancy studies, surveillance, natural history studies, disease and drug registries, and comparative effectiveness research. Dr. Bratton often consults with early clinical R&D programs in shaping RWE needs and goals within regulatory expectations. Her analytic capabilities range from descriptive to more advanced epidemiologic methods.
Emily received her MSPH in Epidemiology (2008) and PhD in Infectious Disease Epidemiology (2012) from the University of North Carolina at Chapel Hill where she now holds an adjunct assistant professor position. Before her graduate studies, Dr. Bratton studied evolutionary biology, molecular genetics and
microbiology (Colgate University, Duke University Medical Center). She is based in Research Triangle Park, NC (USA).
Disclosure(s): Cone Health: Employment (Ongoing); IQVIA: Employment (Ongoing)
Meet the Expert in the Real-World: Real-World Data in Drug Development and Utilization - Part 1
Thursday, March 28, 2024
9:30 AM – 10:30 AM MDT
Meet the Expert in the Real-World: Real-World Data in Drug Development and Utilization - Part 2
Thursday, March 28, 2024
1:30 PM – 2:30 PM MDT